Paul Tudor Jones’s Pyxis Oncology PYXS Stock Holding History

Paul Tudor Jones’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,624	Closed	-$55K	–	2837
2023 Q1	$55K	Hold	13,624	–	–	﹤0.01%	2282
2022 Q4	$18K	Hold	13,624	–	–	﹤0.01%	2270
2022 Q3	$27K	Hold	13,624	–	–	﹤0.01%	2203
2022 Q2	$32K	Hold	13,624	–	–	﹤0.01%	1988
2022 Q1	$55K	Hold	13,624	–	–	﹤0.01%	1861
2021 Q4	$149K	Buy	+13,624	New	+$156K	﹤0.01%	2205

Other funds holding PYXS

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paul Tudor Jones's PYXS Position: Q2 2023 in Review

Paul Tudor Jones sold out of Pyxis Oncology (PYXS) in Q2 2023, closing a stake of 13,624 shares — an estimated $55K sold.

Paul Tudor Jones first reported a position in PYXS in Q4 2021 and held it in 6 quarters. The position peaked at $149K in Q4 2021. 48 funds tracked by Wall St. Rank hold PYXS as of Q2 2023.

Paul Tudor Jones reported no remaining Pyxis Oncology position as of Q2 2023 after selling out during the quarter.
Paul Tudor Jones sold 13,624 Pyxis Oncology shares in Q2 2023, an estimated $55K.
Paul Tudor Jones first reported a position in Pyxis Oncology in Q4 2021 and held it in 6 quarters.
Paul Tudor Jones's Pyxis Oncology position peaked at $149K in Q4 2021.
48 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.